Public-domain · open source
OpenJurist
← 199 F. Supp. 51 - Commonwealth Engineering Co. v. Ladd

199 F. Supp. 51 - Commonwealth Engineering Co. v. Ladd’s Empirical Analysis

1961

Citation profile

19
cited by 19 later decisions
September 1969
most recently cited

5 federal appellate · 3 district ·

Relationships

Applies 35 U.S.C. § 101 · 35 U.S.C. § 145

Relies on Application of John A. Nelson and Anthony C. Shabica · Krimmel · Isenstead v. Watson · Besser v. Merrilat Culvert Core Co.

Most-quoted passages

The sentences later courts lift from this opinion, ranked by how many decisions quote each — the parts of the opinion doing the work. These counts are smaller than the citation total above because most of the 19 citing decisions cite the case generally; a passage count includes only decisions quoting that exact language verbatim.

  1. ““This Court held in Isenstead v. Watson, 157 F.Supp. 7 [ 115 USPQ 408 ], that the term ‘utility’ is a broad term and implies, among other things, capacity to perform the function or attain the result claimed by the applicant in his disclosure. It further held that, in connection with a composition of matter, the test of utility is whether the invention will attain the purpose and will operate as disclosed and claimed by the inventor. Similarly, in connection with an invention consisting of a process or a method, the term ‘utility’ must necessarily mean whether the process will operate as claimed and will produce the result intended by the inventor.’’ [Emphasis added.]”
    2 later decisions quote this exact passage · from the majority
  2. ““Great care and scrutiny should be particularly taken in connection with applications for medical patents. While the granting of a patent does not legally constitute a certificate that the medicine to which it relates is a good medicine and will cure the disease or successfully make the test which it was intended to do, nevertheless, the granting of such a patent gives a kind of official imprimatur to the medicine in question on which as a moral matter some members of the public are likely to rely. In view of these circumstances, it is right and proper that the Patent Office should be very careful and perhaps even reluctant to grant a patent on a new medical formula until it has been thoroughly tested and successfully tried by more than one physician. It seems to the Court that therefore the Patent Office, as a matter of public policy, followed a proper course in this matter.” (157 F.Supp. at p. 9).”
    1 later decision quote this exact passage · from the majority

How this case has been treated — in progress

Whether each later court followed, distinguished, criticized, or overruled this decision. The treatment classification (task #35) runs highest-cited cases first and lights up here as it reaches this one.